Pimecrolimus: A novel treatment for cetuximab-induced papulopustular eruption

被引：7

作者：

Eiling, Elisabeth ^{[1
]}

Brandt, Michael ^{[1
]}

Schwarz, Thomas ^{[1
]}

Hauschild, Axel ^{[1
]}

机构：

[1] Univ Kiel, Dept Dermatol, D-24105 Kiel, Germany

来源：

ARCHIVES OF DERMATOLOGY | 2008年 / 144卷 / 09期

关键词：

D O I：

10.1001/archderm.144.9.1236

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

收藏

页码：1236 / 1238

页数：4

相关论文

共 5 条

[1] Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: Histopathologic and molecular consequences of receptor inhibition
Albanell, J
Rojo, F
Averbuch, S
Feyereislova, A
Mascaro, JM
Herbst, R
LoRusso, P
Rischin, D
Sauleda, S
Gee, J
Nicholson, RI
Baselga, J
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) : 110 - 124
[2] Baselga J, 2002, ONCOLOGIST, V7, P2
[3] Cutaneous side effects of epidermal growth factor receptor inhibitors: Clinical presentation, pathogenesis, and management
Hu, Jenny C.
Sadeghi, Parrish
Pinter-Brown, Lauren C.
Yashar, Sharona
Chin, Melvin W.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : 317 - 326
[4] The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome
Lacouture, M. E.
Lai, S. E.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (04) : 852 - 854
[5] Cutaneous adverse effects with HER1/EGFR-targeted agents:: Is there a silver lining?
Peréz-Soler, R
Saltz, L
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5235 - 5246